Lazertinib

ATC L01EB09 · 10 markets · 17 records

Lazertinib 10 markets · 17 records Forms

US 2 records · 2 strengths

GB 2 records · 2 strengths

CA 2 records · 2 strengths

SG 2 records · 2 strengths

ES 2 records · 2 strengths

TW 2 records · 2 strengths

  • 240 mgtabletLAZCLUZE力安莎膜衣錠240毫克 also in US·GB·CA +2
  • 80 mgtabletLAZCLUZE力安莎膜衣錠80毫克 also in US·GB·CA +2

HK 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

    AU 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      MX 1 records · 1 strengths

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        EU 1 records · 1 strengths

        EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

          1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

          Side-by-side table

          The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

          Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.